farrell nicholas kelland lloyd (11 Ergebnisse)

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,800grams, ISBN:9780896035997.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. In.

Zustand: Used. pp. 356 Illus.

Zustand: Used. pp. 356.

Zustand: New. In.

Taschenbuch. Zustand: Neu. Platinum-Based Drugs in Cancer Therapy | Nicholas P. Farrell (u. a.) | Taschenbuch | xii | Englisch | 2010 | Humana Press | EAN 9781617370915 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Zustand: New. Editor(s): Kelland, Lloyd R.; Farrell, Nicholas P. Series: Cancer Drug Discovery and Development. Num Pages: 341 pages, 5 black & white illustrations, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 232 x 157 x 20. Weight in Grams: 528. . 2010. Softcover reprint of hardcover 1st ed. 2000. paperback. . . . . Books ship from the US and Ireland.

Gebunden. Zustand: New. Leading international experts comprehensively review all aspects of platinum anticancer drugs and their current use in treatment, as well as examining their future therapeutic prospects. Writing from a variety of disciplines, these authorities discuss the c.

Zustand: New. Reviews the aspects of platinum anticancer drugs. This book also examines their therapeutic prospects. It discusses the chemistry of cisplatin in aqueous solution, the molecular interaction of platinum drugs with DNA, and such areas as DNA mismatch repair and replicative bypass, apoptosis, and the transport of platinum drugs into tumor cells. Editor(s): Kelland, Lloyd R.; Farrell, Nicholas P. Series: Cancer Drug Discovery and Development. Num Pages: 341 pages, 5 black & white illustrations, biography. BIC Classification: MJCL2; MMZ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 20. Weight in Grams: 675. . 2000. 2000th Edition. hardcover. . . . . Books ship from the US and Ireland.

Buch. Zustand: Neu. Neuware - Leading international experts comprehensively review all aspects of platinum anticancer drugs and their current use in treatment, as well as examining their future therapeutic prospects. Writing from a variety of disciplines, these authorities discuss the chemistry of cisplatin in aqueous solution, the molecular interaction of platinum drugs with DNA, and such exciting new areas as DNA mismatch repair and replicative bypass, apoptosis, and the transport of platinum drugs into tumor cells. The emergent platinum drugs of the future-orally active agents, the sterically hindered ZD0473, and the polynuclear charged platinum BBR3464-are also fully considered. Timely and interdisciplinary, Platinum-Based Drugs in Cancer Therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs. In Platinum-Based Drugs in Cancer Therapy, leading international experts comprehensively review all aspects of platinum anticancer drugs and their current use in treatment, as well as examining their future therapeutic prospects. Writing from a variety of disciplines, these authorities discuss the chemistry of cisplatin in aqueous solution, the molecular interaction of platinum drugs with DNA, and such exciting new areas as DNA mismatch repair, replicative bypass, apoptosis, and the transport of platinum drugs into tumor cells. The antitumor activity and toxicology of platinum-based drugs is also addressed in a thorough discussion of the clinical experience with cisplatin and carboplatin, including their promising recent combinations with taxanes and oxaliplatin. The emergent platinum drugs of the future-orally active agents, the sterically hindered ZD0473, and the polynuclear charged platinum BBR3464-are also fully considered. Timely and interdisciplinary, Platinum-Based Drugs in Cancer Therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs. This important book captures the essence of the fresh clinical possibilities now strongly emerging thirty years after cisplatin's discovery.